Clinical Trials Directory

Trials / Completed

CompletedNCT01529359

Irritable Bowel Syndrome and Lactibiane Tolerance

Effect of Lactibiane Tolerance on Symptoms Severity of Irritable Bowel Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
123 (actual)
Sponsor
PiLeJe · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the effects of a probiotic combination (Lactibiane Tolerance) on the severity of symptoms in patients with irritable bowel syndrome (IBS).

Detailed description

The primary purpose of this study is to evaluate the effects of a probiotic combination (Lactibiane Tolerance) on the severity of symptoms in patients with irritable bowel syndrome (IBS). The secondary purposes are to evaluate the effects of the intervention on: * quality of life * severity of fatigue, anxiety and depression * levels of inflammatory markers in blood and tools

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLactibiane ToleranceProbiotics combination 2 gelules per days during 6 weeks
DIETARY_SUPPLEMENTPlaceboPlacebo 2 gelules per days for 6 weeks

Timeline

Start date
2010-03-24
Primary completion
2013-02-04
Completion
2013-02-11
First posted
2012-02-08
Last updated
2021-04-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01529359. Inclusion in this directory is not an endorsement.

Irritable Bowel Syndrome and Lactibiane Tolerance (NCT01529359) · Clinical Trials Directory